Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
Recruiting · NCT06782139 · Registry updated 2025-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Phase 4 | 2025-09-02 | NCT06782139 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Daewoong Pharmaceutical Co. LTD. | 38 |
| Korea University Anam Hospital | 54 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Korea University Anam Hospital | Seoul | South Korea | 94 |